β-Amyloid deposition in brain is enhanced in mouse models of arterial hypertension

被引:99
作者
Gentile, Maria Teresa [1 ]
Poulet, Roberta [1 ]
Di Pardo, Alba [1 ]
Cifelli, Giuseppe [1 ]
Maffei, Angelo [1 ]
Vecchione, Carmine [1 ]
Passarelli, Francesca [2 ]
Landolfi, Alessandro [1 ]
Carullo, Pierluigi [1 ]
Lembo, Giuseppe [1 ]
机构
[1] IRCCS Neuromed, Dept Angiocardioneurol, I-86077 Pozzilli, IS, Italy
[2] Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy
关键词
Brain; Hypertension; beta-Amyloid; Blood-brain barrier; Immunotherapy; ALZHEIMERS-DISEASE; PEPTIDE; BARRIER; IMMUNIZATION; CLEARANCE; HYPOTHESIS; TRANSPORT; INSULIN;
D O I
10.1016/j.neurobiolaging.2007.06.005
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
There are conflicting evidence regarding the association of hypertension with Alzheimer's disease (AD), and so far it is still unexplored whether increased blood pressure levels can be mechanistically related to the pathophysiology of AD. since the deposition of beta-amyloid (A beta) in brain represents the first pathogenetic event in the onset of AD, in this Study we investigated the role of hypertension in the brain deposition of A beta. We analyzed two independent Mouse models of hypertension. In both models we observed an increased permeability of blood-brain barrier in cortex and hippocampus. More interestingly, in the same areas hypertensive mice showed a marked positivity to anti-A beta antibodies and the presence of A beta-like fragments. Finally, we analyzed mice after passive immunotherapy with anti-A beta IgG. We observed that this latter approach determined a markedly reduced A beta immunopositivity in both cortex and hippocampus. Our study demonstrates that chronic hypertension determines an impairment of the blood-brain barrier permeability with deposition of A beta in brain tissue and that passive immunotherapy prevents this latter phenomenon. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:222 / 228
页数:7
相关论文
共 36 条
[1]   Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion [J].
Bennett, SAL ;
Pappas, BA ;
Stevens, WD ;
Davidson, CM ;
Fortin, T ;
Chen, J .
NEUROBIOLOGY OF AGING, 2000, 21 (02) :207-214
[2]   Fresh and globular amyloid β protein (1-42) induces rapid cellular degeneration:: evidence for AβP channel-mediated cellular toxicity [J].
Bhatia, R ;
Lin, H ;
Lal, R .
FASEB JOURNAL, 2000, 14 (09) :1233-1243
[3]   Brain microvascular changes in Alzheimer's disease and other dementias [J].
Buee, L ;
Hof, PR ;
Delacourte, A .
CEREBROVASCULAR PATHOLOGY IN ALZHEIMER'S DISEASE, 1997, 826 :7-24
[4]  
Claudio L, 1996, ACTA NEUROPATHOL, V91, P6
[5]   Insulin resistance and Alzheimer's disease pathogenesis: Potential mechanisms and implications for treatment [J].
Craft, Suzanne .
CURRENT ALZHEIMER RESEARCH, 2007, 4 (02) :147-152
[6]  
Das P, 2003, J NEUROSCI, V23, P8532
[7]   Alzheimer disease as a vascular disorder - Nosological evidence [J].
de la Torre, JC .
STROKE, 2002, 33 (04) :1152-1162
[8]   Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis [J].
de la Torre, JC .
NEUROBIOLOGY OF AGING, 2000, 21 (02) :331-342
[9]   The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q [J].
De Simoni, MG ;
Rossi, E ;
Storini, C ;
Pizzimenti, S ;
Echart, C ;
Bergamaschini, L .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (05) :1857-1863
[10]   RAGE (Yin) versus LRP (Yang) balance regulates Alzheimer amyloid β-peptide clearance through transport across the blood-brain barrier [J].
Deane, R ;
Wu, ZH ;
Zlokovic, BV .
STROKE, 2004, 35 (11) :2628-2631